Browse
related articles
Hikma, generic sales to drop
- Jordan: Wednesday, October 25 - 2006 at 08:50
Jordon-based drug maker Hikma, which is listed on the London Stock Exchange, predicts its generic sales will decline this year due to decreasing wholesaler inventories and a lower than forecast contribution from new product launches, Reuters reported. But the company is expecting strong growth for the full year in its branded and injectables businesses.
Related Content
Article Options
James McInerney, News EditorWednesday, October 25 - 2006 at 08:50 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
This article was updated on Sat Jun 09 2007.
Disclaimer »
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
